Allovir, Inc. Annual Share-based Payment Arrangement, Expense in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Allovir, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2019 to 2023.
  • Allovir, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $5.91M, a 42.6% decline year-over-year.
  • Allovir, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $31.4M, a 21.9% decline year-over-year.
  • Allovir, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $40.8M, a 1.3% decline from 2022.
  • Allovir, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $41.3M, a 6.05% decline from 2021.
  • Allovir, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $44M, a 366% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $40.8M -$536K -1.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-15
2022 $41.3M -$2.66M -6.05% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-15
2021 $44M +$34.5M +366% Jan 1, 2021 Dec 31, 2021 10-K 2023-02-15
2020 $9.43M +$6.54M +226% Jan 1, 2020 Dec 31, 2020 10-K 2022-02-10
2019 $2.89M Jan 1, 2019 Dec 31, 2019 10-K 2021-02-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.